Conferences
Conference Details
DESCRIPTION European Due Diligence Summit for Life Sciences Recent years have shown a rise in development across the generic and biosimilar industries, as many blockbuster products near the end of their patents. The need to expand the reach of R&D programmes has driven major new investments in co-development, strategic alliances, licensing and acquisitions, with big pharmaceutical companies scrambling to maintain their strongholds in specific therapeutic areas. This has increased the need for a robust due diligence process across all functions, as companies look to external targets as a means of supplementing pipelines and bolstering their product portfolios.
Date :
Place : United Kingdom, London
Contact Person:Paula Edwards
Description:
DESCRIPTION European Due Diligence Summit for Life Sciences Recent years have shown a rise in development across the generic and biosimilar industries, as many blockbuster products near the end of their patents. The need to expand the reach of R&D programmes has driven major new investments in co-development, strategic alliances, licensing and acquisitions, with big pharmaceutical companies scrambling to maintain their strongholds in specific therapeutic areas. This has increased the need for a robust due diligence process across all functions, as companies look to external targets as a means of supplementing pipelines and bolstering their product portfolios.DESCRIPTION European Due Diligence Summit for Life Sciences Recent years have shown a rise in development across the generic and biosimilar industries, as many blockbuster products near the end of their patents. The need to expand the reach of R&D programmes has driven major new investments in co-development, strategic alliances, licensing and acquisitions, with big pharmaceutical companies scrambling to maintain their strongholds in specific therapeutic areas. This has increased the need for a robust due diligence process across all functions, as companies look to external targets as a means of supplementing pipelines and bolstering their product portfolios. will be held in London,United Kingdom on date 2018-02-27
Deadline for abstracts/proposals : 25th February 2018
Organized By :New York Events List
Keynote Speakers :
Conference Highlights :Top Five Reasons to Attend 1.Explore best practices for companies of all sizes looking to acquire or in-license a product 2.Understand how to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal 3.Learn how to evaluate and effectively manage strategic alliances through case studies from industry leaders 4.Assess the regulatory and compliance standards of a target and how gaps can lead to unforeseen financial burdens 5.G
Venue :London W1H 7BG, United Kingdom
Check the event website for more details.
Views:
650